Healthcare Press

'Significant milestone': HSE approves breast cancer drug

  • 📰 rtenews
  • ⏱ Reading Time:
  • 18 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 99%

News News

The approval by the HSE of a new treatment option for people with breast cancer at high-risk of recurrence, which could reduce the chance of their cancer returning by 30%, has been welcomed as a 'significant milestone'.

The approval by the HSE of a new treatment option for people with breast cancer at high-risk of recurrence, which could reduce the chance of their cancer returning by 30%, has been welcomed as a"significant milestone".

Speaking on RTÉ's Morning Ireland, Prof Walshe said the approval was exciting, adding that it has been awaited for two years. "From our point of view, we're just very keen to get access to this for our patients, because ultimately, it's going to reduce the risk of disease relapse which in itself makes sense for the taxpayer.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Clever '30-30-30 rule' can help boost weight loss and improve overall fitnessThe 30-30-30 rule involves eating 30 grams of protein within 30 minutes of waking up, and then doing 30 minutes of low-intensity exercise
Source: IrishMirror - 🏆 4. / 98 Read more »